Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5.

Nguyen, Tien V; Barry, Mary E; Turner, Mallory A; Crosby, Catherine M; Trujillo, Miguel A; Morris, John C; Barry, Michael A.

Afiliação

Nguyen TV; Department of Internal Medicine, Division of Infectious Diseases, Translational Immunovirology and Biodefense Program, Mayo Clinic, Rochester, MN 55902, USA. nguyen.tien@mayo.edu.
Barry ME; Department of Internal Medicine, Division of Infectious Diseases, Translational Immunovirology and Biodefense Program, Mayo Clinic, Rochester, MN 55902, USA. mbarry@mayo.edu.
Turner MA; Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, MN 55902, USA. mallory.a.turner@gmail.com.
Crosby CM; Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, MN 55902, USA. ccrosby@lji.org.
Trujillo MA; Department of Endocrinology, Mayo Clinic, Rochester, MN 55902, USA. rtrujillo.miguel@mayo.edu.
Morris JC; Department of Endocrinology, Mayo Clinic, Rochester, MN 55902, USA. morris.john@mayo.edu.
Barry MA; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55902, USA. morris.john@mayo.edu.

Biomedicines ; 5(3)2017 Aug 10.

Article em En | MEDLINE | ID: mdl-28796161